quinazolines has been researched along with substance p in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faulhaber, HD; Görne, RC; Hartrodt, W; Homuth, V; Naumann, E; Oehme, P; Pfeiffer, D; Rathsack, R; Rostock, G | 1 |
| Cooper, R; Gillum, AM; Kullnig, R; Kydd, GC; Musza, LL; Wong, SM | 1 |
| Algermissen, B; Bavandi, A; Fischer, E; Handjiski, B; Maurer, M; Paus, R; von Stebut, E | 1 |
| Ganesan, A; Wang, H | 1 |
| Doods, H; Jhamandas, K; Ma, W; Powell, KJ; Quirion, R; Sutak, M | 1 |
| Ahn, K; Fahnoe, DC; Johnson, GD; Knapp, J | 1 |
| Haslett, C; Jodrell, D; MacKinnon, AC; Sethi, T; Waters, C | 1 |
| de Vries, R; Garrelds, IM; Gupta, S; Maassenvandenbrink, A; Mehrotra, S; Saxena, PR; Sharma, HS; van Kats, JP; Villalón, CM | 1 |
| Buhren, BA; Gerber, PA; Homey, B | 1 |
| Almendro, V; Ametller, E; Casas, I; Fernández-Nogueira, P; García-Recio, S; Gascón, P; Mayordomo, C; Pastor-Arroyo, EM; Vinyals, L | 1 |
| Fischer, MJ; Lennerz, JK; Messlinger, K | 1 |
| Andersen, HH; Kullander, K; Lagerström, MC; Rogoz, K | 1 |
| Chmielinska, JJ; Kramer, JH; Mak, IT; Spurney, CF; Weglicki, WB | 1 |
| Aubdool, AA; Bátai, IZ; Brain, SD; Filotás, D; Hajna, Z; Helyes, Z; Nagy, L; Payrits, M; Pintér, E; Pozsgai, G; Sághy, É; Szőke, É | 1 |
1 review(s) available for quinazolines and substance p
| Article | Year |
|---|---|
Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine.
Topics: Animals; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Dura Mater; Humans; Membrane Potentials; Migraine Disorders; Neurokinin A; Neuropeptide Y; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide; Substance P; Trigeminal Ganglion; Trigeminal Nucleus, Spinal; Vasoactive Intestinal Peptide | 2011 |
13 other study(ies) available for quinazolines and substance p
| Article | Year |
|---|---|
Evidence of decreased plasma substance P levels in human essential hypertension and influence of prazosin treatment.
Topics: Adult; Blood Pressure; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Dopamine beta-Hydroxylase; Female; Humans; Hypertension; Male; Norepinephrine; Prazosin; Quinazolines; Renin; Substance P | 1983 |
Fiscalins: new substance P inhibitors produced by the fungus Neosartorya fischeri. Taxonomy, fermentation, structures, and biological properties.
Topics: Cells, Cultured; Chromatography, High Pressure Liquid; Crystallography; Fermentation; Fungi; Humans; Indoles; Quinazolines; Structure-Activity Relationship; Substance P | 1993 |
Activated skin mast cells are involved in murine hair follicle regression (catagen).
Topics: Adrenocorticotropic Hormone; Animals; Cromolyn Sodium; Dose-Response Relationship, Drug; Female; Hair Follicle; Immunohistochemistry; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron; Quinazolines; Skin Physiological Phenomena; Substance P | 1997 |
Total synthesis of the fumiquinazoline alkaloids: solution-phase studies.
Topics: Alkaloids; Antineoplastic Agents; Fungi; ortho-Aminobenzoates; Quinazolines; Substance P; Tryptophan | 2000 |
Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists.
Topics: Animals; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Drug Tolerance; Male; Morphine; Peptide Fragments; Piperazines; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Calcitonin Gene-Related Peptide; Receptors, N-Methyl-D-Aspartate; Substance P | 2000 |
Inhibitor potencies and substrate preference for endothelin-converting enzyme-1 are dramatically affected by pH.
Topics: Aspartic Acid Endopeptidases; Bradykinin; Endothelin-Converting Enzymes; Humans; Hydrogen-Ion Concentration; Metalloendopeptidases; Organophosphonates; Protease Inhibitors; Quinazolines; Substance P; Substrate Specificity; Tetrazoles | 2000 |
Bombesin and substance P analogues differentially regulate G-protein coupling to the bombesin receptor. Direct evidence for biased agonism.
Topics: 3T3 Cells; Animals; Binding Sites; Blotting, Western; Bombesin; Calcium; Cell Line; COS Cells; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Genes, Dominant; GTP-Binding Proteins; Humans; Ligands; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Models, Theoretical; Pertussis Toxin; Phosphorylation; Protein Binding; Quinazolines; Rats; Receptors, Bombesin; Signal Transduction; Substance P; Time Factors; Tumor Cells, Cultured; Tyrphostins; Virulence Factors, Bordetella | 2001 |
Characterisation of CGRP receptors in human and porcine isolated coronary arteries: evidence for CGRP receptor heterogeneity.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adaptor Proteins, Signal Transducing; Adolescent; Adult; Aged; Animals; Calcitonin Gene-Related Peptide; Calcitonin Receptor-Like Protein; Carrier Proteins; Child; Child, Preschool; Colforsin; Coronary Vessels; Cyclic AMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Middle Aged; Piperazines; Potassium Chloride; Protein Isoforms; Quinazolines; Receptor Activity-Modifying Proteins; Receptors, Calcitonin; Receptors, Calcitonin Gene-Related Peptide; Reverse Transcriptase Polymerase Chain Reaction; Substance P; Swine; Time Factors; Transcription Factor Brn-3A; Vasoconstrictor Agents; Vasodilation | 2006 |
More on aprepitant for erlotinib-induced pruritus.
Topics: Antiemetics; Aprepitant; Erlotinib Hydrochloride; Humans; Morpholines; Neurokinin-1 Receptor Antagonists; Off-Label Use; Protein Kinase Inhibitors; Pruritus; Quinazolines; Substance P | 2011 |
Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2.
Topics: Antibodies; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Resistance, Neoplasm; ErbB Receptors; Female; Humans; Lapatinib; Ligands; Male; Neoplasms; Neurokinin-1 Receptor Antagonists; Piperidines; Prostatic Neoplasms; Quinazolines; Receptor, ErbB-2; Receptors, Neurokinin-1; Signal Transduction; Substance P; Trastuzumab | 2012 |
Glutamate, substance P, and calcitonin gene-related peptide cooperate in inflammation-induced heat hyperalgesia.
Topics: Androstanes; Animals; Benzimidazoles; Calcitonin Gene-Related Peptide; Female; Glutamic Acid; Hot Temperature; Hyperalgesia; Inflammation; Male; Mice; Nerve Growth Factor; Neurons, Afferent; Piperazines; Quinazolines; Substance P; TRPV Cation Channels; Vesicular Glutamate Transport Protein 2 | 2014 |
EGFR-TKI, erlotinib, causes hypomagnesemia, oxidative stress, and cardiac dysfunction: attenuation by NK-1 receptor blockade.
Topics: Animals; Aprepitant; Echocardiography; ErbB Receptors; Erlotinib Hydrochloride; Magnesium; Male; Morpholines; Neurokinin-1 Receptor Antagonists; Oxidative Stress; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Ventricular Function, Left | 2015 |
Capsaicin-Sensitive Sensory Nerves Mediate the Cellular and Microvascular Effects of H2S via TRPA1 Receptor Activation and Neuropeptide Release.
Topics: Animals; Calcitonin Gene-Related Peptide; Capsaicin; Cell Line; Cells, Cultured; Dipeptides; Diterpenes; Female; Glyburide; Hydrogen Sulfide; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neurokinin-1 Receptor Antagonists; Potassium Chloride; Quinazolines; Receptors, Neurokinin-1; Sensory Receptor Cells; Substance P; Transient Receptor Potential Channels; Trigeminal Ganglion; TRPA1 Cation Channel; Vasodilation | 2016 |